{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:09:33Z","timestamp":1789826973550,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00216-018-0884-2","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T02:18:02Z","timestamp":1517969882000},"page":"3533-3545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural berberine"],"prefix":"10.1007","volume":"410","author":[{"given":"Emanuele","family":"Porru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Spinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Caliceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"884_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.chroma.2015.09.001","volume":"1428","author":"P Franco","year":"2016","unstructured":"Franco P, Spinozzi S, Pagnotta E, Lazzeri L, Ugolini L, Camborata C, et al. Development of a liquid chromatography\u2013electrospray ionization\u2013tandem mass spectrometry method for the simultaneous analysis of intact glucosinolates and isothiocyanates in Brassicaceae seeds and functional foods. J Chromatogr A. 2016;1428:154\u201361.","journal-title":"J Chromatogr A"},{"key":"884_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","volume":"28","author":"G Marazzi","year":"2011","unstructured":"Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, et al. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011;28:1105.","journal-title":"Adv Ther"},{"key":"884_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1139\/m69-190","volume":"15","author":"AH Amin","year":"1969","unstructured":"Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol. 1969;15:1067\u201376.","journal-title":"Can J Microbiol"},{"key":"884_CR4","first-page":"111","volume":"15","author":"M Sabir","year":"1971","unstructured":"Sabir M, Bhide NK. Study of some pharmacological actions of berberine. (1971). Indian J Physiol Pharmacol. 1971;15:111\u201332.","journal-title":"Indian J Physiol Pharmacol"},{"key":"884_CR5","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1124\/dmd.108.021659","volume":"36","author":"F Qiu","year":"2008","unstructured":"Qiu F, Zhu Z, Kang N, Piao S, Qin G, Yao X. Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab Dispos. 2008;36:2159\u2013216.","journal-title":"Drug Metab Dispos"},{"key":"884_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1479-5876-9-62","volume":"9","author":"Y Li","year":"2011","unstructured":"Li Y, Ren G, Wang YX, Kong WJ, Yang P, Wang YM, et al. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J Transl Med. 2011;9:62.","journal-title":"J Transl Med"},{"key":"884_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jpba.2015.07.031","volume":"115","author":"X Wang","year":"2015","unstructured":"Wang X, Wang S, Ma J, Ye T, Lu M, Fan M, et al. Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS\/MS. J Pharm Biomed Anal. 2015;115:368\u201374.","journal-title":"J Pharm Biomed Anal"},{"key":"884_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.etap.2016.08.003","volume":"46","author":"N Yang","year":"2016","unstructured":"Yang N, Sun R, Zhao Y, He J, Zhen L, Guo J, et al. High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile. Environ Toxicol Pharmacol. 2016;46:319\u201327.","journal-title":"Environ Toxicol Pharmacol"},{"key":"884_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/10717544.2014.885615","volume":"22","author":"F Li","year":"2015","unstructured":"Li F, Song S, Guo Y, Zhao Q, Zhang X, Pan W, et al. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. Drug Deliv. 2015;22:487\u201398.","journal-title":"Drug Deliv"},{"key":"884_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","volume":"29","author":"CW Pouton","year":"2006","unstructured":"Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278\u201387.","journal-title":"Eur J Pharm Sci"},{"key":"884_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ptr.2968","volume":"24","author":"SK Kulkarni","year":"2010","unstructured":"Kulkarni SK, Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 2010;24:317\u201324.","journal-title":"Phytother Res"},{"key":"884_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.sajb.2015.01.005","volume":"97","author":"MA El-Salam","year":"2015","unstructured":"El-Salam MA, Mekky H, El-Naggar EMB, Ghareeb D, El-Demellawy M, El-Fiky F. Hepatoprotective properties and biotransformation of berberine and berberrubine by cell suspension cultures of Dodonaea viscosa and Ocimum basilicum. S Afr J Bot. 2015;97:191\u20135.","journal-title":"S Afr J Bot"},{"key":"884_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","volume":"49","author":"K Wang","year":"2017","unstructured":"Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49:1\u201319.","journal-title":"Drug Metab Rev"},{"key":"884_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fitote.2013.11.010","volume":"92","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Cao S, Wang Y, Xu P, Yan J, Bin W, et al. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells. Fitoterapia. 2014;92:230\u20137.","journal-title":"Fitoterapia"},{"key":"884_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.fitote.2011.09.014","volume":"83","author":"HY Chen","year":"2012","unstructured":"Chen HY, Ye XL, Cui XL, He K, Jin YN, Chen Z, et al. Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. Fitoterapia. 2012;83:67\u201373.","journal-title":"Fitoterapia"},{"key":"884_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/aps.2016.120","volume":"38","author":"N Yang","year":"2017","unstructured":"Yang N, Sun RB, Chen XL, Zhen L, Ge C, Zhao HJ, et al. In vitro assessment of the glucose-lowering effects of berberrubine-9-O-\u03b2-D-glucuronide, an active metabolite of berberrubine. Acta Pharmacol Sin. 2017;38:351.","journal-title":"Acta Pharmacol Sin"},{"key":"884_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.numecd.2017.04.002","volume":"27","author":"C Caliceti","year":"2017","unstructured":"Caliceti C, Rizzo P, Ferrari R, Fortini F, Aquila G, Leoncini E, et al. Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin. Nutr Metab Cardiovasc Dis. 2017;27:552\u201363.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"884_CR18","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1007\/s00216-016-9763-x","volume":"408","author":"C Caliceti","year":"2016","unstructured":"Caliceti C, Calabria D, Roda A. A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells. Anal Bioanal Chem. 2016;408:8755\u201360.","journal-title":"Anal Bioanal Chem"},{"key":"884_CR19","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/s17071623","volume":"17","author":"Q Gui","year":"2017","unstructured":"Gui Q, Lawson T, Shan S, Yan L, Liu Y. The application of whole cell-based biosensors for use in environmental analysis and in medical diagnostics. Sensors. 2017;17:1623.","journal-title":"Sensors"},{"key":"884_CR20","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1021\/acs.biochem.7b00435","volume":"56","author":"CM Rathbun","year":"2017","unstructured":"Rathbun CM, Prescher JA. Bioluminescent probes for imaging biology beyond the culture dish. Biochemistry. 2017;56:5178\u201384.","journal-title":"Biochemistry"},{"key":"884_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1021\/np400607k","volume":"77","author":"S Spinozzi","year":"2014","unstructured":"Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F, et al. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod. 2014;77:766\u201372.","journal-title":"J Nat Prod"},{"key":"884_CR22","unstructured":"Guidance for industry. Q2B validation of analytical procedures. Methodology. 1996."},{"key":"884_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jgm.1473","volume":"12","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Gene Med. 2010;12:561\u20133.","journal-title":"J Gene Med"},{"key":"884_CR24","doi-asserted-by":"publisher","first-page":"e71440","DOI":"10.1371\/journal.pone.0071440","volume":"8","author":"C Caliceti","year":"2013","unstructured":"Caliceti C, Aquila G, Pannella M, Morelli MB, Fortini C, Pinton P, et al. 17\u03b2-Estradiol enhances signalling mediated by VEGF-A-delta-like ligand 4-Notch1 axis in human endothelial cells. PLoS One. 2013;8:e71440.","journal-title":"PLoS One"},{"key":"884_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/348169","volume":"2013","author":"B Rizzo","year":"2013","unstructured":"Rizzo B, Zambonin L, Angeloni C, Leoncini E, Dalla Sega FV, Prata C, et al. Steviol glycosides modulate glucose transport in different cell types. Oxidative Med Cell Longev. 2013;2013:1\u201311.","journal-title":"Oxidative Med Cell Longev"},{"key":"884_CR26","first-page":"327","volume":"13","author":"A Roda","year":"1998","unstructured":"Roda A, Russo C, Pasini P, Piazza F, Feroci G, Kricka LJ, et al. Antioxidant properties of bile salt micelles evaluated with different chemiluminescent assays: a possible physiological role. Luminescence. 1998;13:327\u201337.","journal-title":"Luminescence"},{"key":"884_CR27","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1002\/jps.23718","volume":"102","author":"JY Ma","year":"2013","unstructured":"Ma JY, Feng R, Tan XS, Ma C, Shou JW, Fu J, et al. Excretion of berberine and its metabolites in oral administration in rats. J Pharm Sci. 2013;102:4181\u201392.","journal-title":"J Pharm Sci"},{"key":"884_CR28","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1124\/dmd.110.033936","volume":"38","author":"YT Liu","year":"2010","unstructured":"Liu YT, Hao HP, Xie HG, Lai L, Wang Q, Liu CX, et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos. 2010;38:1779\u201384.","journal-title":"Drug Metab Dispos"},{"key":"884_CR29","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1124\/dmd.106.011361","volume":"34","author":"F Zuo","year":"2006","unstructured":"Zuo F, Nakamura N, Akao T, Hattori M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography\/ion trap mass spectrometry. Drug Metab Dispos. 2006;34:2064\u201372.","journal-title":"Drug Metab Dispos"},{"key":"884_CR30","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.2174\/0929867323666160411143314","volume":"23","author":"C Caliceti","year":"2016","unstructured":"Caliceti C, Franco P, Spinozzi S, Roda A, Cicero AF. Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Curr Med Chem. 2016;23:1460\u201376.","journal-title":"Curr Med Chem"},{"key":"884_CR31","doi-asserted-by":"crossref","unstructured":"Wang K, Qiao M, Chai L, Cao S, Feng X, Ding L, Qiu F. Identification of berberrubine metabolites in rats by using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Fitoterapia. 2017; article in press.","DOI":"10.1016\/j.fitote.2017.10.005"},{"key":"884_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpba.2017.02.038","volume":"139","author":"K Wang","year":"2017","unstructured":"Wang K, Chai L, Feng X, Liu Z, Liu H, Ding L, et al. Metabolites identification of berberine in rats using ultra-high performance liquid chromatography\/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 2017;139:73\u201386.","journal-title":"J Pharm Biomed Anal"},{"key":"884_CR33","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvp078","volume":"82","author":"Y Wang","year":"2009","unstructured":"Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res. 2009;82:484\u201392.","journal-title":"Cardiovasc Res"},{"key":"884_CR34","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.3892\/mmr.2015.4061","volume":"12","author":"SJ Liu","year":"2015","unstructured":"Liu SJ, Yin CX, Ding MC, Wang YZ, Wang H. Berberine inhibits tumor necrosis factor-alpha-induced expression of inflammatory molecules and activation of nuclear factor-kappaB via the activation of AMPK in vascular endothelial cells. Mol Med Rep. 2015;12:5580\u20136.","journal-title":"Mol Med Rep"},{"key":"884_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/nu9040395","volume":"9","author":"C Caliceti","year":"2017","unstructured":"Caliceti C, Calabria D, Roda A, Cicero AF. Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review. Nutrients. 2017;9:395.","journal-title":"Nutrients"},{"key":"884_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BJ20071196","volume":"409","author":"S Dunn","year":"2008","unstructured":"Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008;409:349\u201355.","journal-title":"Biochem J"},{"key":"884_CR37","unstructured":"Commission Regulation (EU) 2017\/1203 of 5th July 2017."}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-0884-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-0884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-0884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T11:20:59Z","timestamp":1570706459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-0884-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":37,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-0884-2","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were carried out according to the guidelines set forth by EEC Directive 86\/609 on care and use of experimental animals. The protocol was approved by the Institutional Ethics Committee of the University of Bologna (Protocol 398\/2016). All studies involving animals are reported in accordance with the ARRIVE guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}